合成路线1
该中间体在本合成路线中的序号:
(XVIII) The reaction of 3-chloroaniline (X) with choral hydrate (XI) and hydroxylamine gives isonitroso-3-chloroacetanilide (XII), which is cyclized by means of H2SO4 to 4-chloroisatin (XIII). Chlorination of (XIII) with SO2Cl2 affords 4,5-dichloroisatin (XIV), which is oxidized with H2O2 yielding 5,6-dichloroanthranilic acid (XV). The reduction of (XV) with borane in THF gives 6-amino-2,3-dichlorobenzyl alcohol (XVI), which by reaction with SOCl2 in benzene is converted to 6-amino-2,3-dichlorobenzyl chloride (XVII). This compound is condensed with ethyl glycinate (XVIII) by means of triethylamine in refluxing methylene chloride to give ethyl N-(6-amino-2,3-dichlorobenzyl)glycinate (VII), which is cyclized with cyanogen bromide (VIII) in toluene affording ethyl 5,6-dichloro-3,4-dihydro-2-(1H)-iminoquinazoline-3-acetate (IX). Finally, this compound is submitted to a new cyclization by means of triethylamine in refluxing ethanol.
【1】
Jenks, T.A.; Beverung, W.N.Jr.; Partyka, R.A. (Bristol-Myers Squibb Co.); Preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one. CA 1137474 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
29087 |
ethyl 2-[(6-amino-2,3-dichlorobenzyl)amino]acetate
|
|
C11H14Cl2N2O2 |
详情 |
详情
|
(VIII) |
28017 |
cyanic bromide;cyanogen bromide |
506-68-3 |
CBrN |
详情 | 详情
|
(IX) |
29088 |
ethyl 2-[5,6-dichloro-2-imino-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C12H13Cl2N3O2 |
详情 |
详情
|
(X) |
25239 |
3-chloroaniline; 3-chlorophenylamine
|
108-42-9 |
C6H6ClN |
详情 | 详情
|
(XI) |
14018 |
2,2,2-Trichloro-1,1-ethanediol; Chloral hydrate
|
302-17-0 |
C2H3Cl3O2 |
详情 | 详情
|
(XII) |
29089 |
N-(3-chlorophenyl)-2-(hydroxyimino)acetamide
|
|
C8H7ClN2O2 |
详情 |
详情
|
(XIII) |
29090 |
4-chloro-1H-indole-2,3-dione
|
|
C8H4ClNO2 |
详情 |
详情
|
(XIV) |
29091 |
4,5-dichloro-1H-indole-2,3-dione
|
|
C8H3Cl2NO2 |
详情 |
详情
|
(XV) |
29092 |
6-amino-2,3-dichlorobenzoic acid
|
|
C7H5Cl2NO2 |
详情 |
详情
|
(XVI) |
29093 |
(6-amino-2,3-dichlorophenyl)methanol
|
|
C7H7Cl2NO |
详情 |
详情
|
(XVII) |
29094 |
3,4-dichloro-2-(chloromethyl)aniline
|
|
C7H6Cl3N |
详情 |
详情
|
(XVIII) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The condensation of 2-nitro-6-chlorobenzyl chloride (I) with ethyl glycinate (II) by means of triethylamine in refluxing ethanol gives ethyl N-(2-nitro-6-chlorobenzyl)glycinate (III), which is reduced with H2 over Pd/C in ethanol yielding ethyl N-(2-amino-6-chlorobenzyl)glycinate (IV). The cyclization of (IV) with cyanogen bromide (A) in refluxing ethanol affords 6-chloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one (V), which is finally chlorinated with Cl2 and FeCl3 in hot nitromethane.
【1】
Beverung, W.N.Jr.; Partyka, A.; Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones. US 3932407 .
|
【2】
Castaner, J.; Serradell, M.N.; Hillier, K.; Blancafort, P.; Anagrelide hydrochloride. Drugs Fut 1980, 5, 3, 117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
28017 |
cyanic bromide;cyanogen bromide |
506-68-3 |
CBrN |
详情 | 详情
|
(I) |
32683 |
1-Chloro-2-(chloromethyl)-3-nitrobenzene
|
15258-72-7 |
C7H5Cl2NO2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
32684 |
ethyl 2-[(2-chloro-6-nitrobenzyl)amino]acetate
|
50608-25-8 |
C11H13ClN2O4 |
详情 | 详情
|
(IV) |
32685 |
ethyl 2-[(2-amino-6-chlorobenzyl)amino]acetate
|
|
C11H15ClN2O2 |
详情 |
详情
|
(V) |
32686 |
6-chloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
|
61834-95-5 |
C10H8ClN3O |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(V) The nitration of 2,3-dichlorobenzaldehyde (I) with HNO3/H2SO4 gives 2,3-dichloro-6-nitrobenzaldehyde (II), which is reduced with NaBH4 in methanol, yielding 2,3-dichloro-6-nitrobenzyl alcohol (III). The reaction of (III) with SOCl2 and TEA affords the benzyl chloride (IV), which is condensed with glycine ethyl ester (V) by means of TEA to provide the adduct (VI). The reduction of the nitro group of (VI) with SnCl2 in aq. HCl or H2 over PtO2/C in ethanol gives the expected amino derivative (VII), which is cyclized with CN-Br in toluene to yield the iminoquinazoline (VIII). Finally, this compound is further cyclized by means of TEA in water to afford the target imidazoquinazolinone.
【1】
Lang, P.C.; Spencer, R.P.; Yeh, W.-L.; Roth, M.J. (Shire Richwood Inc.); Method for the manufacture of anagrelide. WO 0208228 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14742 |
2,3-dichlorobenzaldehyde
|
6334-18-5 |
C7H4Cl2O |
详情 | 详情
|
(II) |
52800 |
2,3-dichloro-6-nitrobenzaldehyde
|
|
C7H3Cl2NO3 |
详情 |
详情
|
(III) |
52801 |
(2,3-dichloro-6-nitrophenyl)methanol
|
|
C7H5Cl2NO3 |
详情 |
详情
|
(IV) |
52802 |
1,2-dichloro-3-(chloromethyl)-4-nitrobenzene
|
|
C7H4Cl3NO2 |
详情 |
详情
|
(V) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(VI) |
29086 |
ethyl 2-[(2,3-dichloro-6-nitrobenzyl)amino]acetate
|
|
C11H12Cl2N2O4 |
详情 |
详情
|
(VII) |
29087 |
ethyl 2-[(6-amino-2,3-dichlorobenzyl)amino]acetate
|
|
C11H14Cl2N2O2 |
详情 |
详情
|
(VIII) |
29088 |
ethyl 2-[5,6-dichloro-2-imino-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C12H13Cl2N3O2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) The reductocondensation of ethyl glycinate (I) with 2-indanone (II) by means of sodium cyanoborohydride in methanol gives ethyl N-(2-indanyl)glycinate (III), which is condensed with N-benzyloxycarbonyl-L-alanine (IV) by means of isobutyl chlorocarbonate and triethylamine in THF yielding N-(N-benzyloxycarbonyl-L-alanyl)-N-(2-indanyl)glycine ethyl ester (V). The partial hydrolysis of (V) with NaOH in methanol affords N-(N-benzyloxycarbonyl-L-alanyl)-N-(2-indanyl)glycine (VI), which is deprotected by hydrogenolysis with H2 over Pd/C in ethanol giving N-(L-alanyl)-N-(2-indanyl)glycine (VII). Finally, this compound is reductocondensed with ethyl 2-oxo-4-phenylbutanoate (VIII) by means of sodium cyanoborohydride in ethanol.
【1】
Oka, Y.; Nishikawa, K.; Miyake, A. (Takeda Chemical Industries, Ltd.); Bicyclic compounds, their production and use. EP 0051391; GB 2086393; JP 82179141; JP 8277651; US 4385051 .
|
【2】
Serradell, M.N.; Castaner, J.; CV-3317. Drugs Fut 1984, 9, 5, 324.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(II) |
30550 |
1,3-dihydro-2H-inden-2-one
|
615-13-4 |
C9H8O |
详情 | 详情
|
(III) |
30551 |
ethyl 2-(2,3-dihydro-1H-inden-2-ylamino)acetate
|
|
C13H17NO2 |
详情 |
详情
|
(IV) |
61209 |
CBZ-L-Alanine; (2S)-2-[[(Benzyloxy)carbonyl]amino]propionic acid; N-((Phenylmethoxy)carbonyl)-alanine; Carbobenzyloxy-L-alanine
|
|
C11H13NO4 |
详情 |
详情
|
(V) |
30552 |
ethyl 2-[((2S)-2-[[(benzyloxy)carbonyl]amino]propanoyl)(2,3-dihydro-1H-inden-2-yl)amino]acetate
|
|
C24H28N2O5 |
详情 |
详情
|
(VI) |
30553 |
2-[((2S)-2-[[(benzyloxy)carbonyl]amino]propanoyl)(2,3-dihydro-1H-inden-2-yl)amino]acetic acid
|
|
C22H24N2O5 |
详情 |
详情
|
(VII) |
30554 |
2-[[(2S)-2-aminopropanoyl](2,3-dihydro-1H-inden-2-yl)amino]acetic acid
|
|
C14H18N2O3 |
详情 |
详情
|
(VIII) |
20896 |
Ethyl 2-oxo-4-phenylbutanoate; 2-Oxo-4-phenylbutyric acid ethyl ester
|
64920-29-2 |
C12H14O3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) The reaction of 7-fluoro-4-methyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione (I) with POCl3 and N,N-dimethyl-p-toluidine in hot toluene gives 2-chloro-7-fluoro-4-methyl-4,5-dihydro-3H-1,4-benzodiazepin-5 one (II), which is condensed with N-(dimethylaminomethylene)glycine ethyl ester (III) (obtained by condensation of glycine ethyl ester (IV) with dimethylformamide (V) and TEA in dichloromethane) to yield a mixture of intermediates (VI) and (VII). Finally, these compounds are cyclized in refluxing AcOH to provide the target flumazenil.
【1】
Rogers-Evans, M.; Spurr, P.; Hennig, M.; The isolation and use of a benzodiazepine iminochloride for the efficient construction of flumazenil. Tetrahedron Lett 2003, 44, 11, 2425.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31965 |
7-Fluoro-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione; 7-Fluoro-4-methyl-3,4-dihydro-2H-1,4-benzodiazepin-2,5(1H)-dione
|
|
C10H9FN2O2 |
详情 |
详情
|
(II) |
64506 |
2-chloro-7-fluoro-4-methyl-3,4-dihydro-5H-1,4-benzodiazepin-5-one
|
|
C10H8ClFN2O |
详情 |
详情
|
(III) |
64507 |
ethyl 2-{[(E)-(dimethylamino)methylidene]amino}acetate
|
|
C7H14N2O2 |
详情 |
详情
|
(IV) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(V) |
33491 |
Dimethylformamide
|
68-12-2 |
C3H7NO |
详情 | 详情
|
(VI) |
64508 |
ethyl 2-{[(E)-(dimethylamino)methylidene]amino}-2-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-ylidene)acetate
|
|
C17H21FN4O3 |
详情 |
详情
|
(VII) |
64509 |
ethyl 2-{[(E)-(dimethylamino)methylidene]amino}-2-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-ylidene)acetate
|
|
C17H21FN4O3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) Two new syntheses of labeled azamianserin have been described:
1) [13C]-Labeled: The reaction of 2-chloropyridine-3-carbonitrile (I) with glycine ethyl ester (II) by means of Na2CO3 in DMSO gives N-(3-cyanopyridin-2-yl)glycine ethyl ester (III), which by reaction with methylamine in toluene is converted into the corresponding amide (IV). The treatment of (IV) with sodium hypophosphite and RaNi in water-acetic acid-pyridine affords N-(3-formylpyridin-2-yl)glycine methylamide (V), which is reduced with NaBH4 in methanol to the corresponding alcohol (VI). Further reduction of (VI) with LiAlH4 in refluxing dioxane gives 2-[2-(methylamino)ethylamino]-3-pyridinemethanol (VII), which is condensed with [13C]-labeled alpha-bromoacetophenone (VIII) [prepared from labeled benzene (IX) submitted to a Friedel-Crafts condensation with AlCl3 and acetic anhydride to acetophenone (X) and bromination with Br2 in ether] by means of triethylamine in dioxane to afford the substituted acetophenone (XI). The cyclization of (XI) by heating at 120 C yields the tricyclic compound (XII), which is reduced with LiAlH4 - AlCl3 in ethyl ether to give 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol (XIII). Finally, this compound is cyclized in hot H2SO4.
【1】
Wieringa, J.H.; Kaspersen, F.M.; van Rooij, F.A.M.; Sperling, E.G.M.; The synthesis of ORG 3770 labelled with 3H, 13C and 14C. J Label Compd Radiopharm 1989, 27, 9, 1055.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10308 |
2-Chloronicotinonitrile; 2-Chloro-3-cyanopyridine
|
6602-54-6 |
C6H3ClN2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
10310 |
ethyl 2-[(3-cyano-2-pyridinyl)amino]acetate
|
|
C10H11N3O2 |
详情 |
详情
|
(IV) |
10311 |
2-[(3-Cyano-2-pyridinyl)amino]-N-methylacetamide
|
|
C9H10N4O |
详情 |
详情
|
(V) |
10312 |
2-[(3-Formyl-2-pyridinyl)amino]-N-methylacetamide
|
|
C9H11N3O2 |
详情 |
详情
|
(VI) |
10313 |
2-[[3-(Hydroxymethyl)-2-pyridinyl]amino]-N-methylacetamide
|
|
C9H13N3O2 |
详情 |
详情
|
(VII) |
10314 |
(2-[[2-(Methylamino)ethyl]amino]-3-pyridinyl)methanol
|
|
C9H15N3O |
详情 |
详情
|
(VIII) |
10315 |
2-Bromo-1-phenyl-ethanone; 2-Bromo-1-phenyl-1-ethanone
|
70-11-1 |
C8H7BrO |
详情 | 详情
|
(VIII) |
44642 |
2-bromo-1-phenyl-1-ethanone
|
|
C8H7BrO |
详情 |
详情
|
(IX) |
13364 |
Benzene
|
71-43-2 |
C6H6 |
详情 | 详情
|
(IX) |
44640 |
benzene
|
|
C6H6 |
详情 |
详情
|
(X) |
10317 |
Acetophenone
|
98-86-2 |
C8H8O |
详情 | 详情
|
(X) |
44641 |
acetophenone
|
|
C8H8O |
详情 |
详情
|
(XI) |
10318 |
2-[(2-[[3-(Hydroxymethyl)-2-pyridinyl]amino]ethyl)(methyl)amino]-1-phenyl-1-ethanone
|
|
C17H21N3O2 |
详情 |
详情
|
(XI) |
44643 |
2-[(2-[[3-(hydroxymethyl)-2-pyridinyl]amino]ethyl)(methyl)amino]-1-phenyl-1-ethanone
|
|
C17H21N3O2 |
详情 |
详情
|
(XII) |
10319 |
8-Methyl-6a-phenyl-7,8,9,10-tetrahydro-5H,6aH-pyrazino[2,1-b]pyrido[2,3-d][1,3]oxazine
|
|
C17H19N3O |
详情 |
详情
|
(XII) |
44644 |
8-methyl-6a-phenyl-7,8,9,10-tetrahydro-5H,6aH-pyrazino[2,1-b]pyrido[2,3-d][1,3]oxazine
|
|
C17H19N3O |
详情 |
详情
|
(XIII) |
10320 |
[2-(4-Methyl-2-phenylpiperazino)-3-pyridinyl]methanol
|
61337-89-1 |
C17H21N3O |
详情 | 详情
|
(XIII) |
44645 |
[2-(4-methyl-2-phenyl-1-piperazinyl)-3-pyridinyl]methanol
|
|
C17H21N3O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VII) 4) The reaction of amine (I) with phenyl cyanate (V) and KH in THF gives N-(5-bromoquinoxalin-6-yl)cyanamide (VI), which is cyclized with ethyl glycinate (VII) in refluxing ethanol to yield 2-(5-bromoquinoxalin-6-imino)imidazolidin-4-one (AGN-192119).
5) The reaction of cyanamide (VI) with 2-aminoacetaldehyde diethyl acetal (VIII) affords N1-(5-bromoquinoxalin-6-yl)-N3-(2,2-diethoxyethyl)guanidine (IX), which is cyclized by means of HCl to the hydroxyimidazoline (X). Finally, this compound is treated with NaOH to afford 5-bromo-6-(2-imidazolylamino)quinoxaline (AGN-192076).
【1】
Tang-Liu, D.; Burke, J.; Garst, M.; Harcourt, D.; Acheampong, A.; Breau, A.; Munk, S.A.; Wong, H.; Lai, R.; Wheeler, L.; Synthesis and characterization of degradation products and
metabolites of brimonidine - A potent alpha2 adrenergic agonist. 211th ACS Natl Meet (March 24-28, New Orleans) 1996, Abst MEDI 021. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
AGN-192119 |
62987 |
2-[(5-bromo-6-quinoxalinyl)imino]-4-imidazolidinone
|
|
C11H8BrN5O |
详情 |
详情
|
AGN-192076 |
62988 |
5-bromo-N-(1H-imidazol-2-yl)-6-quinoxalinamine; N-(5-bromo-6-quinoxalinyl)-N-(1H-imidazol-2-yl)amine
|
|
C11H8BrN5 |
详情 |
详情
|
(I) |
10328 |
5-Bromo-6-quinoxalinamine; 5-Bromo-6-quinoxalinylamine
|
|
C8H6BrN3 |
详情 |
详情
|
(V) |
62986 |
phenyl cyanate
|
|
C7H5NO |
详情 |
详情
|
(VI) |
10330 |
N-(5-Bromo-6-quinoxalinyl)cyanamide
|
|
C9H5BrN4 |
详情 |
详情
|
(VII) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(VIII) |
10331 |
2,2-Diethoxy-1-ethanamine; 2,2-Diethoxyethylamine; Aminoacetaldehyde diethyl acetal
|
645-36-3 |
C6H15NO2 |
详情 | 详情
|
(IX) |
10332 |
N-(5-Bromo-6-quinoxalinyl)-N'-(2,2-diethoxyethyl)guanidine
|
|
C15H20BrN5O2 |
详情 |
详情
|
(X) |
10333 |
2-[(5-Bromo-6-quinoxalinyl)amino]-4,5-dihydro-1H-imidazol-5-ol
|
|
C11H10BrN5O |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(A) 1) The alkylation of 2-amino-5-chlorobenzophenone (I) with 2,2,2-trifluoroethyl trichloromethansulfonate (II) in refluxing xylene gives the N-trifluoroethyl derivative (III), which is then cyclized with glycine ethyl ester (A) in refluxing pyridine.
2) Compound (III) can also be bromoacetylated with bromoacetyl bromide (B) in refluxing benzene yielding the N-bromoacetyl compound (IV), which is then cyclized with ammonia in CHCl3.
3) By alkylation of 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (IX) with NaOMe and 2,2,2-trifluoroethyl iodide in MeOH.
【1】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
【2】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
【3】
Topliss, J.G.; Verfahren zur Herstellung von neuen 1,4-benzodiazepinen bzw. ihren 4-Oxyden. CH 505842; DE 1793682; FR 1518382; GB 1179125 .
|
【4】
Castaner, J.; Thorpe, P.; Halazepam. Drugs Fut 1978, 3, 2, 109.
|
【5】
Topliss, J.G.; Steinman, M.; Alekel, R.; Wong, Y.S.; York, E.E.; 1-Polyfluoroalkylbenzodiazepines. J Med Chem 1973, 16, 12, 1354-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
18806 |
1,1,1-trifluoro-2-iodoethane
|
353-83-3 |
C2H2F3I |
详情 | 详情
|
(A) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(B) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(I) |
10279 |
(2-Amino-5-chlorophenyl)(phenyl)methanone; 2-Amino-5-chlorobenzophenone
|
719-59-5 |
C13H10ClNO |
详情 | 详情
|
(II) |
33474 |
2,2,2-Trifluoroethyl trichloromethanesulfonate; 2,2,2-Trifluoroethyl trichloromethylsulfonate
|
23199-56-6 |
C3H2Cl3F3O3S |
详情 | 详情
|
(III) |
33848 |
[5-chloro-2-[(2,2,2-trifluoroethyl)amino]phenyl](phenyl)methanone
|
|
C15H11ClF3NO |
详情 |
详情
|
(IV) |
33849 |
N-(2-benzoyl-4-chlorophenyl)-2-bromo-N-(2,2,2-trifluoroethyl)acetamide
|
|
C17H12BrClF3NO2 |
详情 |
详情
|
(IX) |
10281 |
7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1,4-benzdiazepin-2-one-5-phenyl-7-chloro
|
1088-11-5 |
C15H11ClN2O |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The condensation of 1-methyl-5-(4-methylbenzoyl)pyrrole-2-acetic acid (I) with glycine ethyl ester (II) by means of carbonyldiimidazole (CDI) and triethylamine in THF gives the corresponding acetamidoacetate (III), which is hydrolyzed with NaOH in THF-water yielding 2-[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetamido]acetic acid (IV). Finally, this compound is esterified with 2-methoxyphenol (guayacol) (V) by means of CDI in hot THF.
【1】
Baglioni, A. (Medosan; Sigma-Tau); Pyrroleacetic acid amides, their preparation and use. BE 0896018 .
|
【2】
Serradell, M.N.; Castaner, J.; Castaner, R.M.; Arrigoni-Martelli, E.; ST-679. Drugs Fut 1989, 14, 10, 963.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11352 |
2-[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid
|
|
C15H15NO3 |
详情 |
详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
21363 |
ethyl 2-([2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]amino)acetate
|
|
C19H22N2O4 |
详情 |
详情
|
(IV) |
21364 |
2-([2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]amino)acetic acid
|
|
C17H18N2O4 |
详情 |
详情
|
(V) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(IX) The syntheses of the metabolites of grepafloxacin, 7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro quinoline-3-carboxylic acid (III), 7-(2-aminopropylamino)-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydr oquinoline-3-carboxylic acid (V), 7-amino-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-ca rboxylic acid (VIII), 7-(carboxymethylamino)-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydr oquinoline-3-carboxylic acid (XI), 1-cyclopropyl-6-fluoro-5-(hydroxymethyl)-7-(3-methylpiperazin-1-yl)-4-o xo-1,4-dihydroquinoline-3-carboxylic acid (XVIII) and 7-amino-1-cyclopropyl-6-fluoro-5-(hydroxymethyl)-4-oxo-1,4-dihydroquino line-3-carboxylic acid (XX) have been reported:
1) Compound (III): By condensation of 7-bromo-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-ca rboxylic acid diacetoxyborane ester (I) with 2-(tert-butoxycarbonylamino)ethylamine (II) by heating at 110 C followed by a treatment with HCl in ethanol/water.
2) Compound (V): By condensation of quinolone (I) with 2-(tert-butoxycarbonylamino)ethylamine (IV) by heating at 110 C, followed by hydrolysis with HCl as before.
3) Compound (VIII): The condensation of quinolone (I) with 4-methoxybenzylamine (VII) by heating at 110 C gives 1-cyclopropyl-6-fluoro-7-(4-methoxybenzylamino)-5-methyl-4-oxo-1,4-dihy droquinoline-3-carboxylic acid (VII), which is then debenzylated by treatment with a mixture of trifluoroacetic acid and concentrated sulfuric acid.
4) Compound (XI): The condensation of quinolone (I) with glycine ethyl ester (IX) by heating at 110 C gives 1-cyclopropyl-7-(ethoxycarbonylmethylamino)-6-fluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (X), which is then saponified with NaOH in refluxing ethanol.
【1】
Otsubo, K.; Kawano, Y.; Ohguro, K.; Uchida, M.; Ohtani, T.; Ohmori, K.; Matsubara, J.; Morita, S.; Synthesis of possible metabolites of 1-cyclopropyl-1,4-dihydro-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (grepafloxacin, OPC-17116). Chem Pharm Bull 1995, 43, 12, 2246. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15093 |
diacetyl (7-bromo-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinyl)carbonyl borate
|
|
C18H16BBrFNO7 |
详情 |
详情
|
(II) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(III) |
15095 |
7-[(2-aminoethyl)amino]-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C16H18FN3O3 |
详情 |
详情
|
(IV) |
15096 |
tert-butyl N-(2-amino-1-methylethyl)carbamate
|
|
C8H18N2O2 |
详情 |
详情
|
(V) |
15097 |
7-[(2-aminopropyl)amino]-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C17H20FN3O3 |
详情 |
详情
|
(VI) |
15098 |
4-Methoxybenzylamine; (4-Methoxyphenyl)methanamine
|
2393-23-9 |
C8H11NO |
详情 | 详情
|
(VII) |
15099 |
1-cyclopropyl-6-fluoro-7-[(4-methoxybenzyl)amino]-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C22H21FN2O4 |
详情 |
详情
|
(VIII) |
15100 |
7-amino-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C14H13FN2O3 |
详情 |
详情
|
(IX) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(X) |
15102 |
1-cyclopropyl-7-[(2-ethoxy-2-oxoethyl)amino]-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C18H19FN2O5 |
详情 |
详情
|
(XI) |
15103 |
7-[(carboxymethyl)amino]-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C16H15FN2O5 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) Condensation of imidate (I) with glycine ethyl ester (II) in refluxing acetone yielded imidazolone (III). Subsequent alkylation with N-triphenylmethyl-5-[4'-bromomethyl)biphenyl-2-yl]tetrazole (IV) in the presence of potassium tert-butoxide in cold DMF provided (V), which was finally deprotected by refluxing in a methanolic solution of AcOH to afford the title compound.
【1】
Okazaki, T.; et al.; Studies of nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidine-3,5-dihydro-4H-imidazol-4-one derivatives. Chem Pharm Bull 1998, 46, 5, 777.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(I) |
18737 |
ethyl butanimidoate
|
|
C6H13NO |
详情 |
详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
18739 |
5-(1-methylethylidene)-2-propyl-3,5-dihydro-4H-imidazol-4-one
|
|
C9H14N2O |
详情 |
详情
|
(IV) |
15538 |
5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-2-trityl-2H-1,2,3,4-tetraazole
|
124750-51-2 |
C33H25BrN4 |
详情 | 详情
|
(V) |
18741 |
5-(1-methylethylidene)-2-propyl-3-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-3,5-dihydro-4H-imidazol-4-one
|
|
C42H38N6O |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(III) The reaction of ethyl valerimidate hydrochloride (I) with cyanamide in ethanol yielded cyanoimidate (II), which was converted into the cyanoimidoylglycine (IV) on treatment with glycine ethyl ester (III) and triethylamine. Alkylation of (IV) with the biphenyl derivative (V) in the presence of 1 mole of NaH in DMF gave the intermediate cyanoamidine (VI), which, by further addition of half an equivalent of sodium hydride was cyclized to the imidazole (VII). Acylation of (VII) with 3,3-dimethylacryloyl chloride (VIII) in cold pyridine yielded amide (IX), and then N-alkylation with iodomethane and sodium hydride in DMF provided (X). Acidic treatment with acetic acid in refluxing ethanol removed the trityl group to give (XI).
【1】
Okazaki, T.; et al.; Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives. Chem Pharm Bull 1998, 46, 6, 973.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15120 |
ethyl pentanimidoate
|
|
C7H15NO |
详情 |
详情
|
(II) |
17804 |
ethyl N-cyanopentanimidoate
|
|
C8H14N2O |
详情 |
详情
|
(III) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(IV) |
17806 |
ethyl 2-(pentanimidoylamino)acetate
|
|
C10H17N3O2 |
详情 |
详情
|
(V) |
65045 |
5-[4'-(bromomethyl)[1,1'-biphenyl]-2-yl]-1-trityl-1H-1,2,3,4-tetraazole
|
|
C33H25BrN4 |
详情 |
详情
|
(VI) |
17808 |
ethyl 2-(pentanimidoyl[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]amino)acetate
|
|
C43H41N7O2 |
详情 |
详情
|
(VII) |
17809 |
ethyl 4-amino-2-butyl-1-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
|
|
C43H41N7O2 |
详情 |
详情
|
(VIII) |
17810 |
3-methyl-2-butenoyl chloride; 3,3-Dimethylacryloyl chloride
|
3350-78-5 |
C5H7ClO |
详情 | 详情
|
(IX) |
17811 |
ethyl 2-butyl-4-[(3-methyl-2-butenoyl)amino]-1-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
|
|
C48H47N7O3 |
详情 |
详情
|
(X) |
17812 |
ethyl 2-butyl-4-[methyl(3-methyl-2-butenoyl)amino]-1-[[2'-(1-trityl-1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
|
|
C49H49N7O3 |
详情 |
详情
|
(XI) |
17813 |
ethyl 2-butyl-4-[methyl(3-methyl-2-butenoyl)amino]-1-[[2'-(1H-1,2,3,4-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
|
|
C30H35N7O3 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) The reaction of isatoic anhydride (I) with glycine ethyl ester (II) gives N-(2-aminobenzoyl)glycine ethyl ester (III), which is cyclized with carbonyldiimidazole (CDI) to yield 2-(2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)acetic acid ethyl ester (IV). The alkylation of (IV) with 3,4-dichlorobenzyl bromide (V) affords 2-[1-(3,4-dichlorobenzyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl]acetic acid ethyl ester (VI), which is finally hydrolyzed in basic medium.
【1】
Itoh, Y.; Hashimoto, M.; Ao, S.; Notsu, Y.; Novel aldose reductase inhibitors: Synthesis and structure-activity studies of (3-benzyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetic acids. Drugs Fut 1992, 17, 1, 31.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
42909 |
ethyl 2-[(2-aminobenzoyl)amino]acetate
|
|
C11H14N2O3 |
详情 |
详情
|
(IV) |
42910 |
ethyl 2-[2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C12H12N2O4 |
详情 |
详情
|
(V) |
42911 |
4-(bromomethyl)-1,2-dichlorobenzene
|
18880-04-1 |
C7H5BrCl2 |
详情 | 详情
|
(VI) |
42912 |
ethyl 2-[1-(3,4-dichlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C19H16Cl2N2O4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) The addition of glycine ethyl ester (I) to 2-propenenitrile (II) by means of KOH in water gives N-(2-cyanoethyl)glycine ethyl ester (III), which is cyclized by means of di-tert-butyl dicarbonate yielding the protected pyrrolidinone (IV). The reduction of (IV) with NaBH4 in ethanol affords the pyrrolidinol (V), which is further reduced with LiAlH4 in THF and protected with di-tert-butyl dicarbonate to give the fully N-protected compound (VI). The oxidation of (VI) with pyridine/SO3 complex yields the pyrrolidinone (VII), which is treated with O-methylhydroxylamine (VIII) to afford the correponding oxime (IX). The deprotection of (IX) with acetyl chloride in cool methanol gives 4-(aminomethyl)pyrrolidin-3-one O-methyloxime (X), which is finally condensed with 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (XI) by means of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in acetonitrile.
【1】
Kim, Y.K.; Chang, J.H.; Choi, H.; Hong, C.Y.; Nam, D.H.; Kim, Y.Z.; Kim, S.H.; Kwak, J.H.; Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: Synthesis and antibacterial activity of LB20304. J Med Chem 1997, 40, 22, 3584-93. |
【2】
Graul, A.; Castañer, J.; SB-265805/LB-20304a. Drugs Fut 1998, 23, 11, 1199-1204.
|
【3】
Kwak, J.H.; Jeong, Y.N.; Oh, J.I. (LG Chem Ltd.); Novel quinoline carboxylic acid derivs. having 7-(4-amino-methyl-3-oxime)pyrrolidine substituents and processes for their preparation. CA 2151890; EP 0688772; JP 1996041050; US 5633262; US 5698570; US 5776944 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(II) |
10847 |
Acrylonitrile
|
107-13-1 |
C3H3N |
详情 | 详情
|
(III) |
17731 |
ethyl 2-[(2-cyanoethyl)amino]acetate
|
|
C7H12N2O2 |
详情 |
详情
|
(IV) |
17732 |
tert-butyl 3-cyano-4-oxo-1-pyrrolidinecarboxylate
|
|
C10H14N2O3 |
详情 |
详情
|
(V) |
17733 |
tert-butyl 3-cyano-4-hydroxy-1-pyrrolidinecarboxylate
|
|
C10H16N2O3 |
详情 |
详情
|
(VI) |
17734 |
tert-butyl 3-[[(tert-butoxycarbonyl)amino]methyl]-4-hydroxy-1-pyrrolidinecarboxylate
|
|
C15H28N2O5 |
详情 |
详情
|
(VII) |
17735 |
tert-butyl 3-[[(tert-butoxycarbonyl)amino]methyl]-4-oxo-1-pyrrolidinecarboxylate
|
|
C15H26N2O5 |
详情 |
详情
|
(VIII) |
15455 |
(aminooxy)methane; O-methylhydroxylamine
|
67-62-9 |
CH5NO |
详情 | 详情
|
(IX) |
17737 |
tert-butyl 3-[[(tert-butoxycarbonyl)amino]methyl]-4-(methoxyimino)-1-pyrrolidinecarboxylate
|
|
C16H29N3O5 |
详情 |
详情
|
(X) |
17738 |
4-(aminomethyl)-3-pyrrolidinone O-methyloxime
|
|
C6H13N3O |
详情 |
详情
|
(XI) |
17034 |
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid
|
100361-18-0 |
C12H8ClFN2O3 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II) The title compound has been obtained by two related ways: Condensation of glycine ethyl ester (II) with 2,4-difluoronirobenzene (I) provided the N-arylglycine (III), which was further reduced to the phenylenediamine derivative (IV) by catalytic hydrogenation. Acylation of diamine (IV) with ethyl chloroglyoxylate, followed by ring closure in refluxing ethanol, yielded the quinoxalinedione (V). Subsequent electrophyllic nitration of (V) furnished the 6-nitroquinoxaline (VI). The fluoride group of (III) was then displaced with imidazole (VII) in hot DMF yielding the imidazolyl quinoxaline (VIII). Finally, basic hydrolysis of the ethyl ester function of (VIII) gave the target carboxylic acid.
【1】
Shishikura, J.; Inami, H.; Sakamoto, S.; Tsukamoto, S.; Sasamata, M.; Okada, M.; Fujii, M. (Yamanouchi Pharmaceutical Co., Ltd.); 1,2,3,4-Tetrahydroquinoxalindione deriv.. EP 0784054; US 6096743; WO 9610023 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
58528 |
ethyl 2-(5-fluoro-2-nitroanilino)acetate
|
|
C10H11FN2O4 |
详情 |
详情
|
(IV) |
58529 |
ethyl 2-(2-amino-5-fluoroanilino)acetate
|
|
C10H13FN2O2 |
详情 |
详情
|
(V) |
58530 |
ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H11FN2O4 |
详情 |
详情
|
(VI) |
58531 |
ethyl 2-[7-fluoro-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H10FN3O6 |
详情 |
详情
|
(VII) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VIII) |
58532 |
ethyl 2-[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C15H13N5O6 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(I) Ethyl glycinate (I) was converted to the 2-aminoacetohydroxamic acid (II) by reaction with hydroxylamine in the presence of KOH in aqueous MeOH. Subsequent cyclization of (II) upon treatment with formaldehyde provided the target 3-hydroxyimidazolin-4-one.
【1】
Audinot, V.; Millan, M.; Cordi, A.; Lacoste, J.-M.; Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands. Bioorg Med Chem Lett 1999, 9, 10, 1409.
|
【2】
Cordi, A.; Lacoste, J.-M.; Millan, M.; Audinot, V. (ADIR et Cie.); 4-Imidazolidinone cpds.. EP 0780379; US 5677325 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(II) |
24602 |
2-amino-N-hydroxyacetamide
|
|
C2H6N2O2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(V) The hydrogenation of 5-methoxy-1H-indole (I) by means of NaCNBH3 in acetic acid gives 5-methoxyindoline (II), which is benzoylated with benzonitrile (III) by means of BCl3/AlCl3 in dichloroethane yielding 7-benzoyl-5-methoxyindoline (IV). The cyclization of (IV) with glycine ethyl ester (V) in pyridine affords the pyrrolo[1,4]benzodiazepine (VI), which is treated with amyl nitrite in toluene/THF to provide the oxime (VII). The reduction of (VII) with H2 over Ru/C in methanol gives the racemic amine (VIII), which is submitted to optical resolution with di-p-toluoyl-D-tartaric acid yielding the corresponding (R)-isomer (IX). Finally, this compound is condensed with 1H-indole-2-carboxylic acid (X) by means of TOTU and DIEA in dichloromethane.
【1】
Feru, F.; et al.; Synthesis and structure-activity relationships of 9-methoxy-4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indolines: Novel PDE 4 inhibitors. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 049.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
40665 |
cyclopentyl nitrite
|
|
C5H9NO2 |
详情 |
详情
|
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
25903 |
5-methoxyindoline; 2,3-dihydro-1H-indol-5-yl methyl ether
|
|
C9H11NO |
详情 |
详情
|
(III) |
25904 |
benzonitrile
|
100-47-0 |
C7H5N |
详情 | 详情
|
(IV) |
25905 |
(5-methoxy-2,3-dihydro-1H-indol-7-yl)(phenyl)methanone
|
|
C16H15NO2 |
详情 |
详情
|
(V) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(VI) |
25906 |
9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H16N2O2 |
详情 |
详情
|
(VII) |
25907 |
9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indole-3,4-dione 3-oxime
|
|
C18H15N3O3 |
详情 |
详情
|
(VIII) |
25908 |
3-amino-9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H17N3O2 |
详情 |
详情
|
(IX) |
25909 |
(3R)-3-amino-9-methoxy-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C18H17N3O2 |
详情 |
详情
|
(X) |
25226 |
1H-Indole-2-carboxylic acid; Indole-2-carboxylic acid
|
1477-50-5 |
C9H7NO2 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) Nalpha-(Benzyloxycarbonyl)-1,4-diaminobutyric acid (I) was protected as the Nomega-Boc derivative (II) and then coupled to glycine ethyl ester (III) by means of EDC and HOBt to produce dipeptide (IV). Hydrogenolysis of the benzyloxycarbonyl group of (IV) to give (V), followed by condensation with alpha-toluenesulfonyl chloride (VI) gave sulfonamide (VII). Side-chain deprotection of (VII) with HCl liberated amine (VIII), which was acylated with 2-pyrazinecarboxylic acid (IX) to afford amide (X). Saponification of the ethyl ester of (X) with LiOH gave carboxylic acid (XI).
【1】
Ho, J.Z.; et al.; Exploration solid-phase synthesis of factor Xa inhibitors: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates. Bioorg Med Chem Lett 1999, 9, 24, 3459.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37250 |
(2R)-4-amino-2-[[(benzyloxy)carbonyl]amino]butyric acid
|
62234-40-6 |
C12H16N2O4 |
详情 | 详情
|
(II) |
37251 |
(2R)-2-[[(benzyloxy)carbonyl]amino]-4-[(tert-butoxycarbonyl)amino]butyric acid
|
|
C17H24N2O6 |
详情 |
详情
|
(III) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(IV) |
37252 |
ethyl 2-([(2R)-2-[[(benzyloxy)carbonyl]amino]-4-[(tert-butoxycarbonyl)amino]butanoyl]amino)acetate
|
|
C21H31N3O7 |
详情 |
详情
|
(V) |
37253 |
ethyl 2-([(2R)-2-amino-4-[(tert-butoxycarbonyl)amino]butanoyl]amino)acetate
|
|
C13H25N3O5 |
详情 |
详情
|
(VI) |
25151 |
phenylmethanesulfonyl chloride
|
1939-99-7 |
C7H7ClO2S |
详情 | 详情
|
(VII) |
37254 |
ethyl 2-([(2R)-2-[(benzylsulfonyl)amino]-4-[(tert-butoxycarbonyl)amino]butanoyl]amino)acetate
|
|
C20H31N3O7S |
详情 |
详情
|
(VIII) |
37255 |
ethyl 2-([(2R)-4-amino-2-[(benzylsulfonyl)amino]butanoyl]amino)acetate
|
|
C15H23N3O5S |
详情 |
详情
|
(IX) |
37256 |
2-pyrazinecarboxylic acid; Pyrazinoic acid
|
98-97-5 |
C5H4N2O2 |
详情 | 详情
|
(X) |
37257 |
ethyl 2-([(2R)-2-[(benzylsulfonyl)amino]-4-[(2-pyrazinylcarbonyl)amino]butanoyl]amino)acetate
|
|
C20H25N5O6S |
详情 |
详情
|
(XI) |
37258 |
2-([(2R)-2-[(benzylsulfonyl)amino]-4-[(2-pyrazinylcarbonyl)amino]butanoyl]amino)acetic acid
|
|
C18H21N5O6S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(XXI) The synthesis of the intermediate carboxylic acid (XV) has been reported by an alternative procedure. The cyclic anhydride (III) was condensed with glycine ethyl ester (XXI) in refluxing Ac2O, yielding the cyclic imide (XXII). Reduction of the imide (XXII) with NaBH4 produced the aminal (XXIII), which was subsequently converted to the more reactive acetoxyamide (XXIV). Boron trifluoride-catalyzed addition of propargyl trimethylsilane (XXV) to the acetoxyamide (XXIV) gave rise to allene (XXVI). This underwent smooth ozonolysis to the aldehyde (XXVII). After protection of the aldehyde (XXVII) as the dimethyl acetal (XIV), hydrolysis of the ethyl ester group gave the intermediate carboxylic acid (XV).
【1】
Reich, S.; Guo, C.X.; Villafranca, E.; Showalter, R.; Dong, L.; A concise synthesis of AG5473/5507 utilizing N-acyliminium ion chemistry. Tetrahedron Lett 2000, 41, 28, 5307.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
43292 |
benzyl 2,4-dioxo-3-oxa-9-azabicyclo[3.3.1]nonane-9-carboxylate
|
|
C15H15NO5 |
详情 |
详情
|
(XIV) |
43302 |
benzyl 2-(dimethoxymethyl)-3-(2-ethoxy-2-oxoethyl)-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C22H30N2O7 |
详情 |
详情
|
(XV) |
43303 |
2-[9-[(benzyloxy)carbonyl]-2-(dimethoxymethyl)-4-oxo-3,9-diazabicyclo[3.3.1]non-3-yl]acetic acid
|
|
C20H26N2O7 |
详情 |
详情
|
(XXI) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(XXII) |
43307 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2,4-dioxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C19H22N2O6 |
详情 |
详情
|
(XXIII) |
43308 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-hydroxy-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C19H24N2O6 |
详情 |
详情
|
(XXIV) |
43309 |
benzyl 2-(acetoxy)-3-(2-ethoxy-2-oxoethyl)-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C21H26N2O7 |
详情 |
详情
|
(XXV) |
43310 |
trimethyl(2-propynyl)silane
|
13361-64-3 |
C6H12Si |
详情 | 详情
|
(XXVI) |
43311 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-oxo-4-(1,2-propadienyl)-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C22H26N2O5 |
详情 |
详情
|
(XXVII) |
43312 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-formyl-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C20H24N2O6 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XXI) The synthesis of the intermediate carboxylic acid (XV) has been reported by an alternative procedure. The cyclic anhydride (III) was condensed with glycine ethyl ester (XXI) in refluxing Ac2O, yielding the cyclic imide (XXII). Reduction of the imide (XXII) with NaBH4 produced the aminal (XXIII), which was subsequently converted to the more reactive acetoxyamide (XXIV). Boron trifluoride-catalyzed addition of propargyl trimethylsilane (XXV) to the acetoxyamide (XXIV) gave rise to allene (XXVI). This underwent smooth ozonolysis to the aldehyde (XXVII). After protection of the aldehyde (XXVII) as the dimethyl acetal (XIV), hydrolysis of the ethyl ester group gave the intermediate carboxylic acid (XV).
【1】
Reich, S.; Guo, C.X.; Villafranca, E.; Showalter, R.; Dong, L.; A concise synthesis of AG5473/5507 utilizing N-acyliminium ion chemistry. Tetrahedron Lett 2000, 41, 28, 5307.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
43292 |
benzyl 2,4-dioxo-3-oxa-9-azabicyclo[3.3.1]nonane-9-carboxylate
|
|
C15H15NO5 |
详情 |
详情
|
(XIV) |
43302 |
benzyl 2-(dimethoxymethyl)-3-(2-ethoxy-2-oxoethyl)-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C22H30N2O7 |
详情 |
详情
|
(XV) |
43303 |
2-[9-[(benzyloxy)carbonyl]-2-(dimethoxymethyl)-4-oxo-3,9-diazabicyclo[3.3.1]non-3-yl]acetic acid
|
|
C20H26N2O7 |
详情 |
详情
|
(XXI) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(XXII) |
43307 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2,4-dioxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C19H22N2O6 |
详情 |
详情
|
(XXIII) |
43308 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-hydroxy-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C19H24N2O6 |
详情 |
详情
|
(XXIV) |
43309 |
benzyl 2-(acetoxy)-3-(2-ethoxy-2-oxoethyl)-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C21H26N2O7 |
详情 |
详情
|
(XXV) |
43310 |
trimethyl(2-propynyl)silane
|
13361-64-3 |
C6H12Si |
详情 | 详情
|
(XXVI) |
43311 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-oxo-4-(1,2-propadienyl)-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C22H26N2O5 |
详情 |
详情
|
(XXVII) |
43312 |
benzyl 3-(2-ethoxy-2-oxoethyl)-2-formyl-4-oxo-3,9-diazabicyclo[3.3.1]nonane-9-carboxylate
|
|
C20H24N2O6 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(A) By cyclocondensation of 2-methylamino-3-(o-chlorobenzoyl)-5-ethylthiophene (I) with ethyl glycinate hydrochloride (A) in pyridine.
【1】
Castaner, J.; Chartterjee, S.S.; Clotiazepan. Drugs Fut 1976, 1, 8, 363.
|
【2】
Nakanishi, M.; et al. (Yoshitomi Pharmaceutical Industries Ltd.); DE 2107356 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(I) |
60743 |
(2-chlorophenyl)[5-ethyl-2-(methylamino)-3-thienyl]methanone
|
|
C14H14ClNOS |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(IV) Friedel-Crafts condensation of indoline (I) with benzonitrile (II) in the presence of BCl3 and AlCl3 produced ketone (III), which was subsequently cyclized to (V) by treatment with ethyl glycinate (IV) in refluxing pyridine. The primary amino group was then introduced by conversion of (V) into oxime (VI) with isoamyl nitrite and potassium tert-butoxide, followed by catalytic hydrogenation over Ru/C to produce amine (VII) (1). The racemic amine was resolved by recrystallization as the corresponding salt with N-acetyl-L-phenylalanine to yield the desired (R)-isomer (VIII). Nitration of (VIII) with KNO3 in H2SO4 gave (IX), which was reduced to the diamino derivative (X) using stannous chloride. Finally, regioselective coupling of (X) at the aliphatic amino group with nicotinic acid (XI) by means of O-[(ethoxycarbonyl)cyanomethyleneamino]-N,N,N',N'-tetramethyluronium tetrafluoroborate (TOTU) provided the target amide.
【2】
Pascal, Y.; Jacobelli, H.; Calvet, A.; Payne, A.; Dahl, S.G. (Institut de Recherche Jouveinal); Diazepino-indoles as phosphodiesterase IV inhibitors. EP 0828742; US 5972927; WO 9736905 .
|
【1】
Burnouf, C.; Auclair, E.; Avenel, N.; et al.; Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[]1,4]diazepino[6,7,1-]indoles: Discovery of potent, selective phosphodiesterase type 4 inhibitors. J Med Chem 2000, 43, 25, 4850. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19652 |
indoline
|
496-15-1 |
C8H9N |
详情 | 详情
|
(II) |
25904 |
benzonitrile
|
100-47-0 |
C7H5N |
详情 | 详情
|
(III) |
47455 |
2,3-dihydro-1H-indol-7-yl(phenyl)methanone
|
|
C15H13NO |
详情 |
详情
|
(IV) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(V) |
47456 |
1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C17H14N2O |
详情 |
详情
|
(VI) |
47457 |
1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indole-3,4-dione 3-oxime
|
|
C17H13N3O2 |
详情 |
详情
|
(VII) |
47458 |
3-amino-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C17H15N3O |
详情 |
详情
|
(VIII) |
47459 |
(3R)-3-amino-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C17H15N3O |
详情 |
详情
|
(IX) |
47460 |
(3R)-3-amino-9-nitro-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C17H14N4O3 |
详情 |
详情
|
(X) |
47461 |
(3R)-3,9-diamino-1-phenyl-6,7-dihydro[1,4]diazepino[6,7,1-hi]indol-4(3H)-one
|
|
C17H16N4O |
详情 |
详情
|
(XI) |
10752 |
Nicotinic acid; Niacin
|
59-67-6 |
C6H5NO2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) Michael addition of ethyl acrylate (I) to glycine ethyl ester (II) produces the amino diester (III), which is protected as the allyl carbamate (IV) by treatment with allyl chloroformate. Dieckmann cyclization of diester (IV) in the presence of NaH leads to pyrrolidinone (V). After reduction of (V) to the corresponding alcohol (VI) with NaBH4, dehydration by means of methanesulfonyl chloride and pyridine furnishes the conjugated ester (VII). Acid (VIII), obtained by alkaline hydrolysis of (VII), is then condensed with magnesium tert-butyl malonate in the presence of CDI to produce keto ester (IX). Chlorination of (IX) with sulfuryl chloride, followed by acidic decarboxylation gives rise to chloro ketone (X). This is then condensed with ammonium dithiocarbamate to generate the 2-mercapto thiazole (XI)
【1】
Sunagawa, M.; Itoh, M.; Kubota, K.; et al.; New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems. J. Antibiot. 2002, 55, 8, 722.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10164 |
ethyl acrylate
|
140-88-5 |
C5H8O2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
61451 |
ethyl 3-[(2-ethoxy-2-oxoethyl)amino]propanoate
|
|
C9H17NO4 |
详情 |
详情
|
(IV) |
61452 |
ethyl 3-[[(allyloxy)carbonyl](2-ethoxy-2-oxoethyl)amino]propanoate
|
|
C13H21NO6 |
详情 |
详情
|
(V) |
61453 |
1-allyl 3-ethyl 4-oxo-1,3-pyrrolidinedicarboxylate
|
|
C11H15NO5 |
详情 |
详情
|
(VI) |
61454 |
1-allyl 3-ethyl 4-hydroxy-1,3-pyrrolidinedicarboxylate
|
|
C11H17NO5 |
详情 |
详情
|
(VII) |
61455 |
1-allyl 3-ethyl 2,5-dihydro-1H-pyrrole-1,3-dicarboxylate
|
|
C11H15NO4 |
详情 |
详情
|
(VIII) |
61456 |
1-[(allyloxy)carbonyl]-2,5-dihydro-1H-pyrrole-3-carboxylic acid
|
|
C9H11NO4 |
详情 |
详情
|
(IX) |
61457 |
allyl 3-[3-(tert-butoxy)-3-oxopropanoyl]-2,5-dihydro-1H-pyrrole-1-carboxylate
|
|
C15H21NO5 |
详情 |
详情
|
(X) |
61458 |
allyl 3-(2-chloroacetyl)-2,5-dihydro-1H-pyrrole-1-carboxylate
|
|
C10H12ClNO3 |
详情 |
详情
|
(XI) |
61459 |
allyl 3-(2-sulfanyl-1,3-thiazol-4-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate
|
|
C11H12N2O2S2 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(X) Acylation of glycine ethyl ester (X) with ethyl oxalyl chloride (XI) provides the oxalic acid mono-amide (XII). Subsequent condensation of (XII) with aminoacetaldehyde dimethylacetal (XIII) affords the diamide (XIV). Cyclization of (XIV) under acetal hydrolysis conditions leads to pyrazinone (XV). This is then brominated to (XVI) employing POBr3 in refluxing dichloroethane. Condensation of the bromopyrazinone (XVI) with amine (IX) at 120 C in a sealed vessel furnishes the aminopyrazinone (XVII). After chlorination of (XVII) with N-chlorosuccinimide, the resultant chloropyrazine ester (XVIII) is hydrolyzed to acid (XIX) under alkaline conditions
【1】
Selnick, H.G.; Rittle, K.E.; Barrow, J.C.; Morrissette, M.M.; Nantermet, P.G.; Staas, D. (Merck & Co., Inc.); Thrombin inhibitors. WO 0257225 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
63218 |
2-(2-amino-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C7H8F2N2O |
详情 |
详情
|
(X) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(XI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XII) |
63556 |
ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate
|
|
C8H13NO5 |
详情 |
详情
|
(XIII) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XIV) |
63557 |
ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate
|
|
C10H18N2O6 |
详情 |
详情
|
(XV) |
63558 |
ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate
|
|
C8H10N2O4 |
详情 |
详情
|
(XVI) |
63219 |
ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C8H9BrN2O3 |
详情 |
详情
|
(XVII) |
63220 |
2-(2-{[4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C15H16F2N4O4 |
详情 |
详情
|
(XVIII) |
63221 |
2-(2-{[5-chloro-4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C15H15ClF2N4O4 |
详情 |
详情
|
(XIX) |
63222 |
2-(2-{[4-(carboxymethyl)-5-chloro-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C13H11ClF2N4O4 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(I) Acylation of glycine ethyl ester (I) with ethyl oxalyl chloride (II) affords amide (III). Subsequent reaction of (III) with aminoacetaldehyde dimethyl acetal (IV) produces the oxalic acid diamide (V). Cyclization of (V) under acidic conditions furnishes the pyrazine dione (VI), which is further brominated to (VII) employing phosphorus oxybromide.
【1】
Selnick, H.G.; Newton, R.C.; Newton, C.L.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Thrombin inhibitors. WO 0311222 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(II) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(III) |
63556 |
ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate
|
|
C8H13NO5 |
详情 |
详情
|
(IV) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(V) |
63557 |
ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate
|
|
C10H18N2O6 |
详情 |
详情
|
(VI) |
63558 |
ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate
|
|
C8H10N2O4 |
详情 |
详情
|
(VII) |
63219 |
ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C8H9BrN2O3 |
详情 |
详情
|